Evidence map›Paper›PMID 32140631›Full record

ArticleComputational toxicology (Amsterdam, Netherlands)2020

Artificial Intelligence for chemical risk assessment.

Clemens Wittwehr, Paul Blomstedt, John Paul Gosling, Tomi Peltola, Barbara Raffael, Andrea-Nicole Richarz, Marta Sienkiewicz, Paul Whaley, Andrew Worth, Maurice Whelan

Open access · hybridAbstract read
In one paragraph

Article in Computational toxicology (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. A matter of trust: Learning lessons about causality will make qAOPs credible.Computational toxicology (Amsterdam, Netherlands) · 2022
    Review
  9. Review
  10. Article
  11. Computational modelling for the sustainable management of chemicals.Computational toxicology (Amsterdam, Netherlands) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Clemens WittwehrEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Paul BlomstedtAalto University, Espoo, Finland.
John Paul GoslingLeeds University, Leeds, UK.
Tomi PeltolaAalto University, Espoo, Finland.
Barbara RaffaelEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Andrea-Nicole RicharzEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Marta SienkiewiczEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Paul WhaleyLancaster Environment Centre, University Lancaster, UK.
Andrew WorthEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Maurice WhelanEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Joint Research Centre · ITAalto University · FIJohns Hopkins University · USUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the basis for managing the risks of chemical exposure, the Chemical Risk Assessment (CRA) process can impact a substantial part of the economy, the health of hundreds of millions of people, and the condition of the environment. However, the number of properly assessed chemicals falls short of societal needs due to a lack of experts for evaluation, interference of third party interests, and the sheer volume of potentially relevant information on the chemicals from disparate sources. In order to explore ways in which computational methods may help overcome this discrepancy between the number of chemical risk assessments required on the one hand and the number and adequateness of assessments actually being conducted on the other, the European Commission's Joint Research Centre organised a workshop on Artificial Intelligence for Chemical Risk Assessment (AI4CRA). The workshop identified a number of areas where Artificial Intelligence could potentially increase the number and quality of regulatory risk management decisions based on CRA, involving process simulation, supporting evaluation, identifying problems, facilitating collaboration, finding experts, evidence gathering, systematic review, knowledge discovery, and building cognitive models. Although these are interconnected, they are organised and discussed under two main themes: scientific-technical process and social aspects and the decision making process.

Identifiers

PMID32140631
PMCPMC7043333
OpenAlexW2989678067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.